Breaking Finance News

Victrex PLC (LON:VCT) target price held steady at 1,450.00GBX, issued a report today by Exane BNP Paribas

Victrex PLC (LON:VCT) had its target price hold steady to 1,450.00GBX by Exane BNP Paribas in a report released Wednesday October 05, 2016. The new target price indicates improbable upside the company's most recent stock price close.

Boasting a price of 0.00GBX, Victrex PLC (LON:VCT) traded 0.30% higher on the day. With the last stock price close down 9.35% from the 200-day moving average, compared to the Standard & Poor's 500 Index which has decreased -0.01% over the same time period. VCT has recorded a 50-day moving average of 1,549.39GBX and a 200-day moving average of 1,516.12GBX. 330,479 shares of VCT traded hands, up from an average trading volume of 255,356

Recent Performance Chart

Victrex PLC (LON:VCT)

Victrex PLC has 52 week low of 1,275.58GBX and a 52 week high of 1,961.00GBX with a PE ratio of 17.69 and has a market capitalization of 0 GBX.

In addition to Exane BNP Paribas reporting its stock price target, a total of 15 brokerages have issued a ratings update on the company. The average stock price target is 1,716.00GBX with 4 brokerages rating the stock a strong buy, 2 brokerages rating the stock a buy, 9 brokerages rating the stock a hold, 1 brokerage rating the stock a underperform, and finally 0 brokerages rating the stock a sell.

Brief Synopsis On Victrex PLC (LON:VCT)

Victrex plc is a United Kingdom-based holding company. The Company is engaged in the manufacture and sale of high performance polymers. The Company's operating segments are Victrex Polymer Solutions and Invibio Biomaterial Solutions. The Victrex Polymer Solutions segment focuses on its automotive, aerospace, electronics and energy markets. The Invibio Biomaterial Solutions segment focuses on providing specialist solutions for medical device manufacturers. It offers its services to over 15,000 aircrafts in approximately 40 countries across the world. The Company intends to focus on polyaryletherketones (PAEK) in automotive, aerospace, electronics and energy, downstream integration opportunities and extending into other markets. It also focuses on spine, trauma, dental and orthopedics, delivering solutions based on polyetheretherketone (PEEK) and other enabling polymers. The Company's subsidiaries include Victrex Manufacturing Limited, Invibio Limited and Victrex Trading Limited.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *